Natural Product: NPC478390

Natural Product IDNPC478390
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
CIPMGVIJZMPLCL-QHYHZEAJSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey CIPMGVIJZMPLCL-QHYHZEAJSA-N
Standard InCHI InChI=1S/C20H28O3/c1-13-6-9-16-19(2,3)10-5-11-20(16,4)15(13)8-7-14-12-17(21)23-18(14)22/h7,15-16H,1,5-6,8-12H2,2-4H3/b14-7+/t15-,16-,20+/m0/s1
SMILES C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C/C=C/1CC(=O)OC1=O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   316.2 Volume:   344.632
?
Van der Waals volume.
Dense:   0.918 LogP:   4.159
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.723
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.925
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   20.0
TPSA:   43.37
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   0.0 Rings:   3.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.324 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.365 Fsp3:   0.7
MCE-18:   54.353
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.332 Fluc inhibitor:   0.284
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.003
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.911 Promiscuous compounds:   0.063

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.435 MDCK Permeability:   -4.794
Pgp-inhibitor:   0.804 Pgp-substrate:   0.0
PAMPA:   0.011
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.001 30% Bioavailability (F30%):   0.008
50% Bioavailability (F50%):   0.2

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.02
Plasma Protein Binding (PPB):   98.16% Volume Distribution (VD):   0.058
Fu: 1.71%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.015
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.464 CYP1A2-substrate:   0.069
CYP2C19-inhibitor:   0.985 CYP2C19-substrate:   0.02
CYP2C9-inhibitor:   0.081 CYP2C9-substrate:   0.008
CYP2D6-inhibitor:   0.473 CYP2D6-substrate:   0.501
CYP3A4-inhibitor:   0.661 CYP3A4-substrate:   0.026
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.995
HLM stability:   0.999
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.501 Half-life (T1/2):  0.786

ADMET: Toxicity

hERG Blockers:  0.06 hERG Blockers (10um):  0.219
Human Hepatotoxicity (H-HT):  0.675 Drug-induced Liver Injury (DILI):  0.819
AMES Toxicity:  0.138 Rat Oral Acute Toxicity:  0.292
Maximum Recommended Daily Dose:  0.77 Skin Sensitization:  0.988
Carcinogencity:  0.49 Eye Corrosion:  0.1
Eye Irritation:  0.818 Respiratory Toxicity:  0.358
Drug-induced Neurotoxicity:  0.568 Ototoxicity:  0.585
Hematotoxicity:  0.48 Drug-induced Nephrotoxicity:  0.966
Genotoxicity:  0.872 RPMI-8226 Immunitoxicity:  0.051
A549 Cytotoxicity:  0.042 Hek293 Cytotoxicity:  0.137
BCF:   1.962
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.772
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.528
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.22
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO41076 Amomum villosum Species Zingiberaceae Eukaryota Rhizomes n.a. n.a. PMID[31710213]
NPO41076 Amomum villosum Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell line RAW264.7 Mus musculus IC50 = 11000.0 nM PMID[31710213]
NPT2 Others Unspecified n.a. Inhibition = 90.3 % PMID[31710213]
NPT2 Others Unspecified n.a. IC50 = 21100.0 nM PMID[31710213]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC478390 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7551 Intermediate Similarity NPC12170
0.74 Intermediate Similarity NPC217394
0.7115 Intermediate Similarity NPC469
0.7115 Intermediate Similarity NPC478393
0.6863 Remote Similarity NPC144947
0.6852 Remote Similarity NPC478394
0.6604 Remote Similarity NPC79027
0.64 Remote Similarity NPC169275
0.64 Remote Similarity NPC52449
0.6275 Remote Similarity NPC175334
0.6226 Remote Similarity NPC251528
0.6111 Remote Similarity NPC238146
0.6038 Remote Similarity NPC99321
0.5769 Remote Similarity NPC185587
0.5714 Remote Similarity NPC75485
0.5714 Remote Similarity NPC168975
0.566 Remote Similarity NPC189745
0.566 Remote Similarity NPC35655
0.5614 Remote Similarity NPC475709
0.5385 Remote Similarity NPC268039
0.537 Remote Similarity NPC484731
0.5345 Remote Similarity NPC311070
0.5345 Remote Similarity NPC472809
0.5345 Remote Similarity NPC177037
0.5345 Remote Similarity NPC472810
0.5345 Remote Similarity NPC472814
0.5333 Remote Similarity NPC478391
0.5227 Remote Similarity NPC103290
0.52 Remote Similarity NPC60772
0.5085 Remote Similarity NPC478375
0.5082 Remote Similarity NPC489288

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478390 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data